The best hobbies for people with anxiety issues.
Discover the best hobbies for people with anxiety issues, from creative projects to physical activities that reduce stress and help ...
What To Ask Your Provider Before Home Oxygen Use
New prescriptions for home oxygen raise practical concerns. Understanding what to ask your provider before home oxygen use supports confident ...
The Quantified Pancreas
Continuous glucose monitors (CGMs), once reserved almost exclusively for patients with type 1 diabetes and select insulin-dependent populations, are now ...
Teaching the Immune System a Second Language
Cancer vaccines have reentered the policy and investment conversation with unusual persistence over the past two weeks, following reporting on ...
Sealing the Mind’s Perimeter
Over the past two weeks, research linking structured aerobic exercise to stabilization—and in some models partial repair—of the blood-brain barrier ...
Editing the Bacteria We Created
Antibiotic resistance—long framed as a looming catastrophe—is again commanding sustained attention after researchers at UC San Diego unveiled a CRISPR-based ...
Breathing and Immunizing Against Forgetfulness
In a week dense with Alzheimer’s headlines, two research threads have persisted beyond the usual news-cycle churn. A large national ...
The Automation of Judgment
Artificial intelligence in healthcare has moved beyond pilot projects and keynote optimism into operational reality. Over the past several weeks, ...
The Physiology of Belief
Breathwork seminars sell out in corporate conference rooms. Cold plunge tubs now sit beside Pelotons in executive homes. “Regulating the ...
The Near-Sighted Generation
Myopia prevalence has risen dramatically over the past several decades, particularly in East Asia but increasingly across North America and ...
A Quiet Revolution in the Margin: How Device Partnerships Are Rewiring Postoperative Monitoring
What began as discrete point solutions — a pulse oximeter here, a hemodynamic sensor there — is becoming a latticework ...
Margins Tell the Story — Until They Don’t
Over the past two weeks, healthcare financial discourse across earnings calls, investor notes, and sector research briefings has converged on ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more